These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34633294)

  • 41. [Intra- or Postoperative Chemoprophylaxis? (author's transl)].
    Senn HJ
    Langenbecks Arch Chir; 1975 Nov; 339():85-93. PubMed ID: 813077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
    Bjarnadottir O; Romero Q; Bendahl PO; Jirström K; Rydén L; Loman N; Uhlén M; Johannesson H; Rose C; Grabau D; Borgquist S
    Breast Cancer Res Treat; 2013 Apr; 138(2):499-508. PubMed ID: 23471651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reply to 'Meta-analysis procedure for the effect of statin on the recurrence of prostate cancer' by T. Kawada.
    Park H; Schoenfeld J; Mucci L
    Ann Oncol; 2014 Feb; 25(2):543-4. PubMed ID: 24419238
    [No Abstract]   [Full Text] [Related]  

  • 44. Bisphosphonates: beyond prevention of bone metastases.
    Rennert G
    J Natl Cancer Inst; 2011 Dec; 103(23):1728-9. PubMed ID: 22021669
    [No Abstract]   [Full Text] [Related]  

  • 45. Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.
    Ishak-Howard MB; Okoth LA; Cooney KA
    Urology; 2014 Jun; 83(6):1356-61. PubMed ID: 24745796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
    Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
    BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Review article: the role of the perioperative period in recurrence after cancer surgery.
    Gottschalk A; Sharma S; Ford J; Durieux ME; Tiouririne M
    Anesth Analg; 2010 Jun; 110(6):1636-43. PubMed ID: 20435944
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statins: health-promoting agents show promise for breast cancer prevention.
    Kumar AS; Esserman LJ
    Clin Breast Cancer; 2005 Dec; 6(5):455-9. PubMed ID: 16381630
    [No Abstract]   [Full Text] [Related]  

  • 49. [A woman with a disappearing breast].
    Bech AP; Mattijssen EJ
    Ned Tijdschr Geneeskd; 2011; 155(50):A4077. PubMed ID: 22186367
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New prognostic factors for breast cancer recurrence.
    Isaacs C; Stearns V; Hayes DF
    Semin Oncol; 2001 Feb; 28(1):53-67. PubMed ID: 11254867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Towards more conservative surgical and radiation therapy of breast cancer].
    Leidenius M; Vaalavirta L
    Duodecim; 2010; 126(10):1198-203. PubMed ID: 20597349
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Statins attenuate outgrowth of breast cancer metastases.
    Beckwitt CH; Clark AM; Ma B; Whaley D; Oltvai ZN; Wells A
    Br J Cancer; 2018 Oct; 119(9):1094-1105. PubMed ID: 30401978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smoking, obesity, and statin therapy in the prognosis of prostate cancer.
    Daniell HW
    J Clin Oncol; 2010 Nov; 28(31):e643; author reply e645-6. PubMed ID: 20876422
    [No Abstract]   [Full Text] [Related]  

  • 54. Can statin therapy reduce the risk of breast cancer?
    Vogel VG
    J Clin Oncol; 2005 Dec; 23(34):8553-5. PubMed ID: 16260689
    [No Abstract]   [Full Text] [Related]  

  • 55. The role of local treatment in the cure of cancer.
    Tubiana M
    Eur J Cancer; 1992; 28A(12):2061-9. PubMed ID: 1419303
    [No Abstract]   [Full Text] [Related]  

  • 56. Clodronate in metastatic breast cancer.
    Meli M; Rausa L
    N Engl J Med; 1998 Dec; 339(26):1940; author reply 1941. PubMed ID: 9874607
    [No Abstract]   [Full Text] [Related]  

  • 57. A Single-centre, Retrospective, Observational Analysis of Fulvestrant for Recurrent/metastatic Breast Cancer According to Metastatic Site.
    Ozawa H; Sata A; Fukui R; Bun A; Higuchi T; Fujimoto Y; Miyagawa Y; Imamura M; Miyoshi Y
    Anticancer Res; 2019 Oct; 39(10):5653-5662. PubMed ID: 31570463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination of Statins and NSAIDs as a Potential Novel Addition to the Limited Anti-Breast Cancer Weaponry: A True Synergistic Model.
    Talaiezadeh A; Papan AM; Nazari P; Mousavi Ghanavati SP; Ramazani A
    Asian Pac J Cancer Prev; 2019 May; 20(5):1295-1296. PubMed ID: 31127876
    [No Abstract]   [Full Text] [Related]  

  • 59. Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
    Kawaguchi Y; Sakamoto Y; Ito D; Ito K; Arita J; Akamatsu N; Kaneko J; Hasegawa K; Moriya K; Kokudo N
    Biosci Trends; 2017 Nov; 11(5):574-580. PubMed ID: 29081488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study.
    Cattarino S; Seisen T; Drouin SJ; Renard-Penna R; Leon P; Comperat E; Mozer P; Cussenot O; Rouprêt M
    Can J Urol; 2015 Apr; 22(2):7703-8. PubMed ID: 25891333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.